These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 12784540)

  • 21. Hyperforin a constituent of St John's wort (Hypericum perforatum L.) extract induces apoptosis by triggering activation of caspases and with hypericin synergistically exerts cytotoxicity towards human malignant cell lines.
    Hostanska K; Reichling J; Bommer S; Weber M; Saller R
    Eur J Pharm Biopharm; 2003 Jul; 56(1):121-32. PubMed ID: 12837490
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Bioactive constituent production in St. John's Wort in vitro hairy roots. Regenerated plant lines.
    Bertoli A; Giovannini A; Ruffoni B; Guardo AD; Spinelli G; Mazzetti M; Pistelli L
    J Agric Food Chem; 2008 Jul; 56(13):5078-82. PubMed ID: 18553917
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Hyperforin analogues from St. John's wort (Hypericum perforatum).
    Verotta L; Appendino G; Jakupovic J; Bombardelli E
    J Nat Prod; 2000 Mar; 63(3):412-5. PubMed ID: 10757735
    [TBL] [Abstract][Full Text] [Related]  

  • 24. St. John's wort: role of active compounds for its mechanism of action and efficacy.
    Butterweck V; Schmidt M
    Wien Med Wochenschr; 2007; 157(13-14):356-61. PubMed ID: 17704987
    [TBL] [Abstract][Full Text] [Related]  

  • 25. St. John's Wort: is it effective and harmless?
    Biron CR
    RDH; 1999 Jun; 19(6):74-6. PubMed ID: 10895712
    [No Abstract]   [Full Text] [Related]  

  • 26. Comparative evaluation of St. John's wort from different Italian regions.
    Pietta P; Gardana C; Pietta A
    Farmaco; 2001; 56(5-7):491-6. PubMed ID: 11482784
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Investigation of pharmacokinetic data of hypericin, pseudohypericin, hyperforin and the flavonoids quercetin and isorhamnetin revealed from single and multiple oral dose studies with a hypericum extract containing tablet in healthy male volunteers.
    Schulz HU; Schürer M; Bässler D; Weiser D
    Arzneimittelforschung; 2005; 55(10):561-8. PubMed ID: 16294501
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Quantitative analysis of the major constituents of St John's wort with HPLC-ESI-MS.
    Chandrasekera DH; Welham KJ; Ashton D; Middleton R; Heinrich M
    J Pharm Pharmacol; 2005 Dec; 57(12):1645-52. PubMed ID: 16354409
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Quantitative analysis of the active components and the by-products of eight dry extracts of Hypericum perforatum L. (St John's Wort).
    von Eggelkraut-Gottanka SG; Abu Abed S; Müller W; Schmidt PC
    Phytochem Anal; 2002; 13(3):170-6. PubMed ID: 12099108
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The main components of St John's Wort inhibit low-density lipoprotein atherogenic modification: a beneficial "side effect" of an OTC antidepressant drug?
    Laggner H; Schreier S; Hermann M; Exner M; Mühl A; Gmeiner BM; Kapiotis S
    Free Radic Res; 2007 Feb; 41(2):234-41. PubMed ID: 17364950
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Hyperforin in St. John's wort--drug, extraction and preparations].
    Lang F; Biber A; Erdelmeier C
    Pharm Unserer Zeit; 2002; 31(5):512-4. PubMed ID: 12369170
    [No Abstract]   [Full Text] [Related]  

  • 32. Modulation of P-glycoprotein function by St John's wort extract and its major constituents.
    Weber CC; Kressmann S; Fricker G; Müller WE
    Pharmacopsychiatry; 2004 Nov; 37(6):292-8. PubMed ID: 15551196
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effects of two different extracts of St. John's wort and some of their constituents on cytochrome P450 activities in rat liver microsomes.
    Nöldner M; Chatterjee S
    Pharmacopsychiatry; 2001 Jul; 34 Suppl 1():S108-10. PubMed ID: 11518056
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Differential accumulation of hyperforin and secohyperforin in Hypericum perforatum tissue cultures.
    Charchoglyan A; Abrahamyan A; Fujii I; Boubakir Z; Gulder TA; Kutchan TM; Vardapetyan H; Bringmann G; Ebizuka Y; Beerhues L
    Phytochemistry; 2007 Nov; 68(21):2670-7. PubMed ID: 17643455
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Variability in St. John's wort formulations is an important consideration.
    Kroll DJ; Shaw HS; Wall ME; Oberlies NH
    Altern Ther Health Med; 2001; 7(6):21-2. PubMed ID: 11712467
    [No Abstract]   [Full Text] [Related]  

  • 36. Determination of natural populations to be included in breeding program in St. John's wort species (
    Uysal Bayar F
    PeerJ; 2024; 12():e18336. PubMed ID: 39430564
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Inhibition of human cytochrome P450 enzymes by constituents of St. John's Wort, an herbal preparation used in the treatment of depression.
    Obach RS
    J Pharmacol Exp Ther; 2000 Jul; 294(1):88-95. PubMed ID: 10871299
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Inhibitory effect of the antidepressant St. John's wort (hypericum perforatum) on rat bladder contractility in vitro.
    Capasso R; Borrelli F; Capasso F; Mascolo N; Izzo AA
    Urology; 2004 Jul; 64(1):168-72. PubMed ID: 15245964
    [TBL] [Abstract][Full Text] [Related]  

  • 39. In vitro photochemical and phototoxicological characterization of major constituents in St. John's Wort (Hypericum perforatum) extracts.
    Onoue S; Seto Y; Ochi M; Inoue R; Ito H; Hatano T; Yamada S
    Phytochemistry; 2011 Oct; 72(14-15):1814-20. PubMed ID: 21782201
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Stimulation of hippocampal acetylcholine release by hyperforin, a constituent of St. John's Wort.
    Kiewert C; Buchholzer ML; Hartmann J; Chatterjee SS; Klein J
    Neurosci Lett; 2004 Jul; 364(3):195-8. PubMed ID: 15196674
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.